Laparoscopic-guided radiofrequency ablation is safe for the treatment of enhancing renal masses among patients prescribed antithrombotic agents

Michael A. Gorin, Jeffery Gahan, Elie Antebi, Robert I. Carey, Vincent G. Bird

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Patients undergoing laparoscopic-guided radiofrequency ablation (LRFA) for the treatment of a renal mass are commonly prescribed antithrombotic agents for the management of comorbid medical diseases. We retrospectively evaluated the safety of LRFA in this group. From October 2005 to June 2010, 109 patients underwent LRFA. Antithrombotic therapy was prescribed to 52 of these patients. Agents were managed the week of surgery per current practice guidelines from the American College of Chest Physicians. Intraoperatively, patients prescribed at least one antithrombotic agent lost a median of 10 mL of blood, while patients not on an antithrombotic agent also lost 10 mL of blood (P =.828). Both groups had a similar rate of procedure-related complications (intraoperative, P = 1.00; postoperative, P =.673). No patient required a blood transfusion or experienced a postoperative thromboembolic event. In conclusion, when current practice guidelines are followed, LRFA is safe among patients prescribed antithrombotic agents.

Original languageEnglish (US)
Pages (from-to)35-39
Number of pages5
JournalClinical and Applied Thrombosis/Hemostasis
Volume18
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Fibrinolytic Agents
Kidney
Practice Guidelines
Therapeutics
Intraoperative Complications
Blood Transfusion
Safety

Keywords

  • antithrombotic
  • aspirin
  • clopidogrel
  • laparoscopic-guided radiofrequency ablation
  • warfarin

ASJC Scopus subject areas

  • Hematology

Cite this

Laparoscopic-guided radiofrequency ablation is safe for the treatment of enhancing renal masses among patients prescribed antithrombotic agents. / Gorin, Michael A.; Gahan, Jeffery; Antebi, Elie; Carey, Robert I.; Bird, Vincent G.

In: Clinical and Applied Thrombosis/Hemostasis, Vol. 18, No. 1, 01.2012, p. 35-39.

Research output: Contribution to journalArticle

@article{21118c99201c4825b2cdb00e21f9868a,
title = "Laparoscopic-guided radiofrequency ablation is safe for the treatment of enhancing renal masses among patients prescribed antithrombotic agents",
abstract = "Patients undergoing laparoscopic-guided radiofrequency ablation (LRFA) for the treatment of a renal mass are commonly prescribed antithrombotic agents for the management of comorbid medical diseases. We retrospectively evaluated the safety of LRFA in this group. From October 2005 to June 2010, 109 patients underwent LRFA. Antithrombotic therapy was prescribed to 52 of these patients. Agents were managed the week of surgery per current practice guidelines from the American College of Chest Physicians. Intraoperatively, patients prescribed at least one antithrombotic agent lost a median of 10 mL of blood, while patients not on an antithrombotic agent also lost 10 mL of blood (P =.828). Both groups had a similar rate of procedure-related complications (intraoperative, P = 1.00; postoperative, P =.673). No patient required a blood transfusion or experienced a postoperative thromboembolic event. In conclusion, when current practice guidelines are followed, LRFA is safe among patients prescribed antithrombotic agents.",
keywords = "antithrombotic, aspirin, clopidogrel, laparoscopic-guided radiofrequency ablation, warfarin",
author = "Gorin, {Michael A.} and Jeffery Gahan and Elie Antebi and Carey, {Robert I.} and Bird, {Vincent G.}",
year = "2012",
month = "1",
doi = "10.1177/1076029611418968",
language = "English (US)",
volume = "18",
pages = "35--39",
journal = "Clinical and Applied Thrombosis/Hemostasis",
issn = "1076-0296",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Laparoscopic-guided radiofrequency ablation is safe for the treatment of enhancing renal masses among patients prescribed antithrombotic agents

AU - Gorin, Michael A.

AU - Gahan, Jeffery

AU - Antebi, Elie

AU - Carey, Robert I.

AU - Bird, Vincent G.

PY - 2012/1

Y1 - 2012/1

N2 - Patients undergoing laparoscopic-guided radiofrequency ablation (LRFA) for the treatment of a renal mass are commonly prescribed antithrombotic agents for the management of comorbid medical diseases. We retrospectively evaluated the safety of LRFA in this group. From October 2005 to June 2010, 109 patients underwent LRFA. Antithrombotic therapy was prescribed to 52 of these patients. Agents were managed the week of surgery per current practice guidelines from the American College of Chest Physicians. Intraoperatively, patients prescribed at least one antithrombotic agent lost a median of 10 mL of blood, while patients not on an antithrombotic agent also lost 10 mL of blood (P =.828). Both groups had a similar rate of procedure-related complications (intraoperative, P = 1.00; postoperative, P =.673). No patient required a blood transfusion or experienced a postoperative thromboembolic event. In conclusion, when current practice guidelines are followed, LRFA is safe among patients prescribed antithrombotic agents.

AB - Patients undergoing laparoscopic-guided radiofrequency ablation (LRFA) for the treatment of a renal mass are commonly prescribed antithrombotic agents for the management of comorbid medical diseases. We retrospectively evaluated the safety of LRFA in this group. From October 2005 to June 2010, 109 patients underwent LRFA. Antithrombotic therapy was prescribed to 52 of these patients. Agents were managed the week of surgery per current practice guidelines from the American College of Chest Physicians. Intraoperatively, patients prescribed at least one antithrombotic agent lost a median of 10 mL of blood, while patients not on an antithrombotic agent also lost 10 mL of blood (P =.828). Both groups had a similar rate of procedure-related complications (intraoperative, P = 1.00; postoperative, P =.673). No patient required a blood transfusion or experienced a postoperative thromboembolic event. In conclusion, when current practice guidelines are followed, LRFA is safe among patients prescribed antithrombotic agents.

KW - antithrombotic

KW - aspirin

KW - clopidogrel

KW - laparoscopic-guided radiofrequency ablation

KW - warfarin

UR - http://www.scopus.com/inward/record.url?scp=84857565235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857565235&partnerID=8YFLogxK

U2 - 10.1177/1076029611418968

DO - 10.1177/1076029611418968

M3 - Article

C2 - 22009987

AN - SCOPUS:84857565235

VL - 18

SP - 35

EP - 39

JO - Clinical and Applied Thrombosis/Hemostasis

JF - Clinical and Applied Thrombosis/Hemostasis

SN - 1076-0296

IS - 1

ER -